7. Samson SL, Vellanki P, Blonde L, et al. American Association of Clinical Endocrinology Consensus Statement:Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update. Endocr Pract. 2023 May;29(5):305-340. doi:10.1016/j.eprac.2023.02.001. Erratum in:Endocr Pract. 2023 Sep;29(9):...
7. Samson SL, Vellanki P, Blonde L, et al. American Association of Clinical Endocrinology Consensus Statement:Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update. Endocr Pract. 2023 May;29(5):305-340. doi:10.1016/j.eprac.2023.02.001. Erratum in:Endocr Pract. 2023 Sep;29(9):...
7. Samson SL, Vellanki P, Blonde L, et al. American Association of Clinical Endocrinology Consensus Statement:Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update. Endocr Pract. 2023 May;29(5):305-340. doi:10...
具体参阅“2型糖尿病治疗策略中的代谢手术:国际糖尿病组织的联合声明(Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations” for a thorough review)”(17)。 随机对照试验证实,在Roux-en-Y胃旁路术(RYGB)患者中,30%-63%的患者在术后随...
[2] Garber AJ, Abrahamson MJ, Barzilay JI, et al. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY[J]. Endocr Pract, 2018, 24(1):91-120....
肥胖症是一种慢性且常为进行性疾病,具有多种医疗、躯体和心理社会并发症,包括2型糖尿病风险大幅增加(1)。有强力且一致的证据表明,肥胖管理可延迟从糖尿病前期向2型糖尿病的进展(2–6);并且在2型糖尿病治疗中有很大的获益(7–18)。 在2型糖尿病伴超重或肥胖患者中,轻中度体重减轻可改善血糖,减少对降糖药物的...
第八部分 l 管理肥胖以治疗2型糖尿病 Obesity Management for the Treatment of Type 2 Diabetes 有强有力且一致的证据表明,肥胖管理可以延缓糖尿病前期到2型糖尿病的进展,并且有益于2型糖尿病的治疗(6-17)。对于超重或肥胖的2型糖尿病患...
* . * Key Point For the second injection, physicians can begin with approximately 4 units of insulin and adjust by 2 units every 3 days until blood glucose is in range. Reference: Nathan DM et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and...
Updated treatment recommendations for type 2 diabetes mellitus have been issued by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Revisions to the treatment algorithm, which was first published in 2006, take into account new medications on the...
这通常在糖尿病自我管理教育和支持(DSMES/ diabetes self-management education and support)的背景下进行。降糖干预措施(从行为干预措施到药物干预措施、设备和手术)的数量不断增加,关于其获益和风险的信息也不断增加,为糖尿病患者和医务人员提供了更多选择,但使决策复杂化。胰高血糖素样肽-1受体激动剂(GLP-1 RA)...